Event Details

January 01, 2019

Description

Cowen Consumer Survey

Participants (1)

Name Type Mentions
respondents person 3 View Entity

Source Documents (2)

HOUSE_OVERSIGHT_024824.jpg

Financial Market Research Report • 1.23 MB
View

This document is page 8 of a Cowen market research report dated February 25, 2019, analyzing the market size and consumer demographics of CBD products. It details survey results from January 2019 showing a 6.9% usage rate, skewing towards younger demographics (18-34), and identifies tinctures as the dominant delivery mechanism. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp (often associated with financial probes into banks connected to Jeffrey Epstein), the content of this specific page is strictly financial market analysis regarding CBD and tobacco/vaping products.

HOUSE_OVERSIGHT_024845.jpg

Market Research Report / Financial Analysis • 1.41 MB
View

This document is page 29 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019, analyzing the CBD tincture market. It presents data on price segmentation among competitors (such as Lord Jones and Lazarus) and consumer demographics regarding tincture usage. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024845', indicating it was obtained during a House Oversight Committee investigation, likely as part of a larger cache of documents from a financial institution, though the content itself is strictly market research.

Related Events

Events with shared participants

Cowen proprietary consumer survey conducted

2019-01-01 • U.S.

View

Newsweek-Daily Beast poll

Date unknown • Global/US

View

Deadline for parties to respond to the United States' letter brief.

2020-09-23 • United States Court of Appeals for the Second Circuit

View

Event Metadata

Type
Unknown
Location
N/A
Significance Score
5/10
Participants
1
Source Documents
2
Extracted
2025-11-19 22:55

Additional Data

Source
HOUSE_OVERSIGHT_024824.jpg
Date String
January 2019

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event